We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Investors seeking momentum may have Xtrackers MSCI Japan Hedged Equity ETF (DBJP - Free Report) on radar now. The fund recently hit a new 52-week high. Shares of DBJP are up approximately 57% from their 52-week low of $29.38/share.
But could there be more gains ahead for this ETF? Let’s take a look at the fund and the near-term outlook to get a better idea of where it might be headed.
DBJP in Focus
The underlying MSCI Japan US Dollar Hedged Index provides exposure to Japanese equity markets, while at the same time mitigating exposure to fluctuations between the value of the U.S. dollar and Japanese yen. The expense ratio is 0.46% (see all Asia-Pacific (Developed) ETFs here).
Why the move?
Japan stocks are on a tear of late. Japan stocks hit a three-decade high after Trump signed stimulus bill. U.S. President Donald Trump signed a $2.3 trillion financial aid and spending bill which includes unemployment benefits to millions, stimulus checks to households. The deal also averts a partial federal government shutdown. Meanwhile, Europe launched a mass Covid-19 vaccination drive on Sunday. All these developments boosted risk-on sentiments and benefited the fund.
More Gains Ahead?
The fund has a positive weighted alpha of 15.80. So, there is a decent outlook ahead for those who want to ride this surging ETF a shade further.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Japan Equity ETF (DBJP) Hits New 52-Week High
Investors seeking momentum may have Xtrackers MSCI Japan Hedged Equity ETF (DBJP - Free Report) on radar now. The fund recently hit a new 52-week high. Shares of DBJP are up approximately 57% from their 52-week low of $29.38/share.
But could there be more gains ahead for this ETF? Let’s take a look at the fund and the near-term outlook to get a better idea of where it might be headed.
DBJP in Focus
The underlying MSCI Japan US Dollar Hedged Index provides exposure to Japanese equity markets, while at the same time mitigating exposure to fluctuations between the value of the U.S. dollar and Japanese yen. The expense ratio is 0.46% (see all Asia-Pacific (Developed) ETFs here).
Why the move?
Japan stocks are on a tear of late. Japan stocks hit a three-decade high after Trump signed stimulus bill. U.S. President Donald Trump signed a $2.3 trillion financial aid and spending bill which includes unemployment benefits to millions, stimulus checks to households. The deal also averts a partial federal government shutdown. Meanwhile, Europe launched a mass Covid-19 vaccination drive on Sunday. All these developments boosted risk-on sentiments and benefited the fund.
More Gains Ahead?
The fund has a positive weighted alpha of 15.80. So, there is a decent outlook ahead for those who want to ride this surging ETF a shade further.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>